CoreFormer high fidelity pulmonary nodule segmentation with structural core priors and geodesic implicit fields.
1/5 보강
Accurate delineation of pulmonary nodules in chest computed tomography (CT) is essential for early lung cancer diagnosis and treatment planning.
APA
Xi Y, Xu C, et al. (2025). CoreFormer high fidelity pulmonary nodule segmentation with structural core priors and geodesic implicit fields.. NPJ digital medicine, 9(1), 48. https://doi.org/10.1038/s41746-025-02221-w
MLA
Xi Y, et al.. "CoreFormer high fidelity pulmonary nodule segmentation with structural core priors and geodesic implicit fields.." NPJ digital medicine, vol. 9, no. 1, 2025, pp. 48.
PMID
41388190 ↗
Abstract 한글 요약
Accurate delineation of pulmonary nodules in chest computed tomography (CT) is essential for early lung cancer diagnosis and treatment planning. However, voxel-wise segmentation methods often produce fragmented masks and inconsistent topology due to low contrast, anatomical variability, and imaging noise. We propose CoreFormer, a segmentation framework that models nodules through structural core anchoring and geodesic shape decoding. CoreFormer identifies the intrinsic topological core of each nodule and generates continuous boundaries guided by anatomy-aware geodesic paths. It is built upon a Swin Transformer backbone and a dual-branch decoder consisting of a Structural Core Predictor and a Context-Aware Shape Decoder, enhanced by Feature Manifold Regularization for discriminative feature learning. Extensive experiments on four public datasets-LIDC-IDRI, LNDb, Tianchi-Lung (MosMedData), and NSCLC-Radiomics-demonstrate that CoreFormer achieves state-of-the-art boundary accuracy and topological fidelity, offering robust and high-fidelity pulmonary nodule segmentation.
같은 제1저자의 인용 많은 논문 (5)
- Klotho-derived peptide preserves erectile function by limiting fibrosis, oxidative stress, and apoptosis of penile smooth muscle cells in cavernous nerve injured-rats through suppression of the TGF-β1/TGF-β type II receptor signaling.
- Association of total and regional fat-to-muscle ratio with the risk of metabolic dysfunction-associated fatty liver disease and other chronic liver diseases.
- Proteasome inhibition by bortezomib augments the efficacy of anti-PD-L1 therapy against lung cancer.
- The role of MYEOV gene: a review and future directions.
- EIF2B5 promotes malignant progression of hepatocellular carcinoma by activating the PI3K/AKT signaling pathway through targeting RPL6.